Governance

Professor Cooper is Sir John Monash Distinguished Professor and Co-Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) at Monash University; and Senior Specialist in Intensive Care at The Alfred Hospital, Melbourne. In 2017, he was awarded an Officer of the Order of Australia (AO) for distinguished service to intensive care medicine in the field of traumatic brain injury as a clinician, and to medical education as an academic, researcher and author. In 2021, Professors Jamie Cooper and Rinaldo Bellomo were jointly awarded the GSK Award for Research Excellence (ARE) in recognition of their global leadership and innovative research in critical care medicine that has helped transform approaches to treatment of critically ill patients worldwide. The GSK ARE is one of the most prestigious awards available to the Australian medical research community. Prof Cooper is a National Health and Medical Research Council (NHMRC) Practitioner Fellow, full Professor of Intensive Care Medicine at Monash University and Hon. Professorial Fellow in the Critical Care and Trauma Division at The George Institute for Global Health, University of Sydney. He was Director of the NHMRC Centre of Research Excellence for Patient Blood Management in Critical Illness and Trauma (Blood-CRE) from 2012-19. He has >400 publications including 18 in New England Journal of Medicine (NEJM), The Lancet, Journal of the American Medical Association (JAMA) and Annals of Internal Medicine. He has been a Principal or Co-investigator on peer reviewed research grants exceeding $83 million including 42 NHMRC/MRFF grants. Research foci include randomised clinical trials in traumatic brain injury, sepsis, acute lung injury, resuscitation fluids, and blood transfusion.

For further information please go to: https://research.monash.edu/en/persons/jamie-cooper

Publications in PubMed

Rinaldo Bellomo is a Professor of Intensive Care Medicine, University of Melbourne, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Monash University, Melbourne Australia; Honorary Professorial Fellow, Faculty of Medicine, The University of NSW, Sydney, Australia; Honorary Professorial Fellow, The George Institute, Sydney, Australia; Honorary Fellow, Florey Institute of Physiology, Melbourne, Australia. In 2018, he was awarded an Officer of the Order of Australia for distinguished service to intensive care medicine as a biomedical scientist and researcher, through infrastructure and systems development to manage the critically ill, and as an author. In 2021, Professors Rinaldo Bellomo and Jamie Cooper were jointly awarded the GSK Award for Research Excellence (ARE) in recognition of their global leadership and innovative research in critical care medicine that has helped transform approaches to treatment of critically ill patients worldwide. The GSK ARE is one of the most prestigious awards available to the Australian medical research community. Professor Bellomo is the Director of Intensive Care Research and Staff Specialist in Intensive Care at Austin Health; Senior Research Advisor and Staff Specialist in Intensive Care at the Department of Intensive Care, Royal Melbourne Hospital, Visiting Staff Specialist in Intensive Care at Warringal Private Hospital in Melbourne and previous Head and now member of the Executive of the Department of Critical Care, The University of Melbourne. He is Co-Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) - a methods centre (established with a National Health and Medical Research Council (NHMRC) Enabling Grant) for investigator-initiated clinical research that supports >15 staff, >10 PhD candidates, and research programs in traumatic brain injury, sepsis, transfusion, acute lung injury, nutrition and health economics. He is a NHMRC Practitioner Fellow and was Foundation Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG). Each year for the past 7 years (2014-2021), Professor Bellomo has been named one of the world's most influential scientific minds of our time. Clarivate Analytics publishes "The world's most influential scientific minds" based on its analysis of data over the previous 11 years using Web of Science and InCites platforms to determine which researchers have produced work that is most frequently acknowledged by peers. Prof Bellomo is one of the researchers identified as "influencing the future direction of their field, and of the world", "on the cutting edge of their field" and "publishing work that their peers recognize as vital to the advancement of their science". He is also the recipient of a NHMRC Achievement Award and an Austin Health Distinguished Scientist Award. In 2015, Professor Bellomo became the first ANZ biomedical researcher to have more than 1,000 papers in Scopus. He has also written more than 152 book chapters and edited 13 books in the field of intensive care medicine. As at October 2021, in the Scopus database, he had >1,812 publications, an h index of 137, and total lifetime citations of >100,000 and a yearly citation rate over the past 5 years of >9,000. He is the most published and most cited medical researcher in the history of Australian medicine. He is the Editor-in-Chief of the journal Critical Care and Resuscitation. Professor Bellomo has been Chief Investigator in many successful grant applications. Over the past 10 years, he has been heavily involved in the design, execution, supervision and publication of several large randomised controlled trials published in The Lancet and the New England Journal of Medicine (NEJM) for >30,000 intensive care unit (ICU) patients randomised.

Publications in PubMed

Alistair is a Professor of Intensive Care Medicine in the School of Public Health and Preventive Medicine, Monash University, and an Intensive Care Clinician at The Alfred Hospital, Melbourne. Following completion of a PhD at University College Dublin, Alistair commenced with the ANZIC-RC in 2007 and has worked on a number of its large multi-centre randomised controlled trials. He was a Chief Investigator on the POLAR-RCT, PHARLAP and EPO-TBI trials. His areas of interest include traumatic brain injury (TBI), acute respiratory distress syndrome (ARDS) and mechanical ventilation. Alistair has completed over 10 years of training in Anaesthesia, Intensive Care and Pain Medicine. He was awarded the Fellowship of the College of Anaesthetists, Royal College of Surgeons Ireland (FCARCSI) in 2002, and the Fellowship of the College of Intensive Care Medicine Australia and New Zealand (FCICM) in 2010. Alistair was also awarded a Victorian Neurotrauma Initiative (VNI) Early Career Practitioner Fellowship.

Publications in PubMed

Prof Andrew Udy is Co-Deputy Director of the Australian and New Zealand Intensive Care Research Centre, Monash University, and a full-time intensive care clinician and researcher at The Alfred ICU, Melbourne. He completed his undergraduate medical education at the University of Auckland, followed by ICU training in New Zealand, the United Kingdom and Australia. After award of Fellowship, Andrew worked as a consultant for many years in Queensland, while also completing a PhD in antibiotic pharmacokinetics. His major academic interests include optimised drug prescribing in the critically ill, haemodynamic management in severe sepsis, acute kidney injury and renal replacement therapy, management of subarachnoid haemorrhage, and critical care nutrition. Andrew is involved in critical care research internationally as the Victorian representative on the ANZICS Clinical Trials Group (CTG) Committee. He is also a keen educator; instructing on BASIC, ALS, ECMO and EMST courses, and is Deputy Chair of the Victorian Regional Committee (VRC), College of Intensive Care Medicine.

Publications in PubMed

Professor Carol Hodgson is Head of the Division of Clinical Trials and Cohort Studies in the School of Public Health and Preventive Medicine, and Deputy Director of the Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia. She has held NHMRC funding throughout her career, as PhD scholarship, Early Career Fellowship and currently with an Investigator Grant (2020-2024). She is a Specialist Physiotherapist in Intensive Care at The Alfred Hospital, Melbourne, Australia. She sits on the Executive and Scientific Committee of the International ECMO Network (ECMONet), the Guidelines Leadership Group for National COVID-19 Clinical Evidence Taskforce and is a Council Member of the International Forum of Acute Care Trialists (InFACT). She leads international multicentre trials for the Australian and New Zealand Intensive Care Society Clinical Trials Group. She has over $20M in grant funding and over 190 publications, with expertise in long-term functional recovery after critical illness. She has contributed to international guidelines for the management of patients with acute respiratory distress syndrome, sepsis and COVID-19, including recommendations for the use of mechanical ventilation, high-flow nasal therapy, oxygen, extracorporeal membrane oxygenation, and early rehabilitation.

Publications

Professor Zoungas is Head of the School of Public Health and Preventive Medicine at Monash University. She is an academic endocrinologist with a national and international reputation as a clinical researcher in the fields of diabetes and vascular risk. In this capacity she directs and supports projects on diabetes, cardiovascular health, kidney health and health care delivery, as well as advise on clinical epidemiological methods and trial design/conduct/reporting. Prof Zoungas is President of the Australian Diabetes Society, a Director on the Board of Diabetes Australia, and Clinical Director of the National Association of Diabetes Centres.

Prof Peake is a Senior Intensive Care Clinician in the Department of Intensive Care Medicine at The Queen Elizabeth Hospital, Adelaide and Professor in the School of Medicine at the University of Adelaide. She is Chair of the Intensive Care Foundation Scientific Committee, Chair of the Research Committee for the Acute Care Medicine Discipline at the University of Adelaide and Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG). She has been an examiner for the College of Intensive Care Medicine for the past 8 years. In 2000, she completed her PhD in Medicine at the University of Adelaide in the field of sepsis. Her thesis examined the role of combination anti-cytokine immunotherapy in an animal model of septic shock. Her main research interest now is large-scale, randomised clinical trials in critical care. She was Chair of the Management Committee for the NHMRC-funded, CTG-endorsed Australasian Resuscitation In Sepsis Evaluation (ARISE) multi-centre trial of early resuscitation in sepsis, and was also a member of the Management Committee for the NHMRC-funded, CTG-endorsed multi-centre clinical trial of Early Parenteral Nutrition.

A/Prof Craig French is a specialist Intensive Care Physician and Anaesthetist. He is the Director of Intensive Care at Western Health, Melbourne, Australia; a Clinical Associate Professor of the University of Melbourne; and the Immediate Past Chair of the ANZICS Clinical Trials Group. His primary interests are multicentre clinical research, clinical ethics, and guideline development.

Professor Dave Pilcher has worked as an Intensive Care Specialist at The Alfred Hospital in Melbourne since 2006. He trained in respiratory and general medicine in the United Kingdom before coming to Australia to complete his Intensive Care fellowship in 2002. Professor Pilcher is Director of the ANZICS Adult Patient Database and the representative of the ANZICS-CORE. He holds an Intensive Care Practitioner fellowship with Monash University. His research interests include organ donation, lung transplantation and the epidemiology of intensive care unit outcomes.

Publications in PubMed

Professor Colin McArthur is a Past Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG). He is a Senior Intensive Care Specialist and Director of Research in the Department of Critical Care Medicine, Auckland City Hospitals; a Member of the Board of Directors, Australia and New Zealand Intensive Care Research Centre (ANZIC-RC) Board and Adjunct Professor (Research) at Monash University; Chair, Clinical Research Review Committee, Auckland District Health Board; Lead REMAP-CAP platform in New Zealand; and Deputy Lead for REMAP-CAP Global Operations. He trained in medicine in Auckland and is a Fellow of the College of Intensive Care Medicine (FCICM) and a Fellow of the Australian and New Zealand College of Anaesthetists (FANZCA). He has been an author of >130 publications, including manuscripts in NEJM (14), JAMA (8) and The Lancet (2). He is a named investigator for >$40 million in research funding including 14 grants as first named / chief investigator. Prof McArthur has been on the management and/or writing committee of numerous NHMRC or HRCNZ-funded studies, including many ANZIC-RC studies (EPO-TBI, EPO-TRAUMA, POLAR, SPICE , ARISE, INFINITE, REMAP-CAP, STATINS, TRANSFUSE). His interests include research methodology and ethics, traumatic brain injury, sepsis, nutrition, and severe influenza; and he has particular experience in adaptive platform trials using Bayesian methods.

Dr Shay McGuinness is Director of Research at the Cardiothoracic and Vascular Intensive Care Unit (CVICU), Auckland City Hospital, New Zealand, and Clinical Director of the Air Ambulance Service, Auckland District Health Board. Dr McGuinness is the New Zealand representative on the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) Executive and is the Chair of the ANZICS-CTG Capacity Working Group Sub-committee. Dr McGuinness trained at medicine and surgery in Sheffield, United Kingdom. He has published more than 25 journal papers including articles in New England Journal of Medicine (NEJM) and Journal of the American Medical Association (JAMA). He has been a Principal or Co-investigator on peer reviewed research grants exceeding (NZ)$2.9 million including 5 NZHRC grants. His research interests include randomised clinical trials in non-invasive ventilation and renal failure. Dr McGuinness is a member of the Management Committee of the ANZIC-RC's  Supplemental PN trial, and was a member on the completed PHARLAP-RCT trial.